A Randomized, Double-Blind, Parallel-Group, Dose-Response Study of Micafungin Compared with Fluconazole for the Treatment of Esophageal Candidiasis in HIV-Positive Patients

de Wet, N.; L. Cuentas, A.; Suleiman, Jamal; Baraldi, Eugenio; Krantz, Edrich; Della Negra, Marinella; Diekmann-Berndt, Heike

doi:10.1086/423377

Public

A Randomized, Double-Blind, Parallel-Group, Dose-Response Study of Micafungin Compared with Fluconazole for the Treatment of Esophageal Candidiasis in HIV-Positive Patients

Published in Clinical Infectious Diseases • Sep 12, 2004

Authors:

N. de Wet

A. L. Cuentas

Jamal Suleiman

Abstract

BACKGROUND: Severely immunocompromised individuals are highly susceptible to Candida infection of the esophagus. This randomized, double-blind study assessed the dose-response relationship of the new echinocandin antifungal, micafungin, compared with that of standard fluconazole treatment. METHODS: ...

Subject

Micafungin

Esophageal candidiasis

Medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!